Bluebook
Diagnostics and Tools February 2024
2024 - February: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Freenome, Inc. closed a $254MM Series A Financing, led by Roche Diagnostics Corporation
- Triple Ring Technologies received funding from 1315 Capital
- Renovaro Biosciences Inc. announced its acquisition of Cyclomics